LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants

被引:109
作者
Aviram, M [1 ]
Fuhrman, B
机构
[1] Rambam Med Ctr, Lipid Res Lab, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Fac Med, Lipid Res Lab, IL-31096 Haifa, Israel
关键词
atherosclerosis; lipoproteins; lipid peroxidation; macrophages; antioxidants; polyphenols; carotenoids;
D O I
10.1023/A:1006841011201
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Oxidized LDL is highly atherogenic as it stimulates macrophage cholesterol accumulation and foam cell formation, it is cytotoxic to cells of the arterial wall and it stimulates inflammatory and thrombotic processes. LDL oxidation can lead to its subsequent aggregation, which further increases cellular cholesterol accumulation. All major cells in the arterial wall including endothelial cells, smooth muscle cells and monocyte derived macrophages can oxidize LDL. Macrophage-mediated oxidation of LDL is probably a hallmark in early atherosclerosis, and it depends on the oxidative state of the LDL and that of the macrophages. The LDL oxidative state is elevated by increased ratio of poly/mono unsaturated fatty acids, and it is reduced by elevation of LDL-associated antioxidants such as vitamin E, beta-carotene, lycopene, and polyphenolic flavonoids. The macrophage oxidative state depends on the balance between cellular NADPH -oxidase and the glutathione system. LDL-associated polyphenolic flavonoids which inhibit its oxidation, can also reduce macrophage oxidative state, and subsequently the cell-mediated oxidation of LDL. Oxidation of the macrophage lipids, which occurs under oxidative stress, can lead to cell-mediated oxidation of LDL even in the absence of transition metal ions, and may be operable in vivo. Finally elimination of Ox-LDL from extracellular spaces, after it was formed under excessive oxidative stress, can possibly be achieved by the hydrolytic action of I-IDL-associated paraoxonase on lipoprotein's lipid peroxides. The present review article summarizes the above issues with an emphasis on our own data.
引用
收藏
页码:149 / 159
页数:11
相关论文
共 76 条
[1]   SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS [J].
ABBOTT, CA ;
MACKNESS, MI ;
KUMAR, S ;
BOULTON, AJ ;
DURRINGTON, PN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) :1812-1818
[2]   Oxidation of low density lipoproteins greatly enhances their association with lipoprotein lipase anchored to endothelial cell matrix [J].
Auerbach, BJ ;
Bisgaier, CL ;
Wolle, J ;
Saxena, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (03) :1329-1335
[3]   DIETARY OLIVE OIL REDUCES LOW-DENSITY-LIPOPROTEIN UPTAKE BY MACROPHAGES AND DECREASES THE SUSCEPTIBILITY OF THE LIPOPROTEIN TO UNDERGO LIPID-PEROXIDATION [J].
AVIRAM, M ;
EIAS, K .
ANNALS OF NUTRITION AND METABOLISM, 1993, 37 (02) :75-84
[4]  
AVIRAM M, 1995, ISRAEL J MED SCI, V31, P241
[5]   THE CONTRIBUTION OF THE MACROPHAGE RECEPTOR FOR OXIDIZED LDL TO ITS CELLULAR UPTAKE [J].
AVIRAM, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 179 (01) :359-365
[6]   LESIONED LOW-DENSITY-LIPOPROTEIN IN ATHEROSCLEROTIC APOLIPOPROTEIN E-DEFICIENT TRANSGENIC MICE AND IN HUMANS IS OXIDIZED AND AGGREGATED [J].
AVIRAM, M ;
MAOR, I ;
KEIDAR, S ;
HAYEK, T ;
OIKNINE, J ;
BAREL, Y ;
ADLER, Z ;
KERTZMAN, V ;
MILO, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (02) :501-513
[7]  
Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599
[8]  
Aviram M, 1996, ISRAEL J MED SCI, V32, P749
[9]   Activation of NADPH oxidase is required for macrophage-mediated oxidation of low-density lipoprotein [J].
Aviram, M ;
Rosenblat, M ;
Etzioni, A ;
Levy, R .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (09) :1069-1079
[10]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590